Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system

Blood

Volumn 90, Issue 4, 1997, Pages 1395-1402

  Sinclair, P B ^b   Green, A R ^b   Grace, C ^b   Nacheva, E P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; INTERFERON;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HUMAN; HUMAN CELL; INTERPHASE; MALE; METAPHASE CHROMOSOME; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030749221     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1395.1395_1395_1402     Document Type: Article

References (42)

1. Gordon MY, Goldman JM: Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment. Br J Haematol 95:10, 1996
2. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature 243:290, 1973
3. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 4). New York, NY, Wiley-Liss, 1991
4. Heim S, Mitelman F: Cancer Cytogenetics. New York, NY, Wiley-Liss, 1995
5. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
6. Westbrook CA, Rubin CM, Carrino JJ, Le Beau MM, Bernards A, Rowley JD: Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. Blood 71:697, 1988
7. van der Plas DC, Grosveld G, Hagemeijer A: Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 52:143, 1991
8. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukaemia phenotype. Blood 88:2375, 1996
9. Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC: A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukaemia. Blood 88:2236, 1996
10. Kantarjian HM, O'Brian S, Anderlini P, Talpaz M: Treatment of chronic myelogenous leukaemia: Current status and investigational options. Blood 87:3069, 1996
11. Lion T: Monitoring of residual disease in chronic myelogenous leukaemia: Methodological approaches and clinical aspects. Leukaemia 10:896, 1996
12. Lin F, van Rhee F, Goldman JM, Cross NC: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87:4473, 1996
13. Cox Froncillo MC, Cantonetti M, Masi M, Lentini R, Giudiceandrea P, Maffei L, Tribalto M, Amadori S, Papa G: Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukaemia (CML) patients on interferon-alpha (IFN-alpha) therapy. Cancer Genet Cytogenet 84:15, 1995
14. McClure JS, Litz CE: Chronic myelogenous leukaemia: Molecular diagnostic considerations. Hum Pathol 25:594, 1994
15. Testoni N, Martinelli G, Farabegoli P, Zaccaria A, Amabile M, Raspadori D, Pelliconi S, Zuffa E, Carboni C, Tura S: A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukaemia patients. Blood 87:3822, 1996
16. Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB: Comparison of BCR-ABL protein expression and Philadelphia chromosome analysis in chronic myelogenous leukaemia patients. Am J Clin Pathol 106:442, 1996
17. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogenous leukaemia by in situ hybridisation. Science 250:559, 1990
18. Calabrese G, Stuppia L, Franchi PG, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A, Palka G: Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 78:153, 1994
19. Nacheva E, Holloway T, Brown K, Bloxham D, Green AR: Philadelphia-negative chronic myeloid leukaemia: Detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22. Br J Haematol 87:409, 1994
20. Jadayel D, Calabrese G, Min T, van Rhee F, Swansbury GJ, Dyer MJ, Maitland J, Pulka G, Catovskj D: Molecular cytogenetics ot chronic myeloid leukaemia with atypical t(6;9)(p23;q34) translocation. Leukaemia 9:981, 1995
21. Haferlach T, Winkemann M, Nickenig C, Meeder M, RammPetersen L, Schoch R, Nickeisen M, Weber-Matthiesen K, Schlegelberger B, Loffer H: All cell lineages are involved in Philadelphiachromosome positive chronic myeloid leukaemia. An investigation at single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridisation. Blood 88:579a, 1996 (abstr, suppl 1)
22. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7, 1993
23. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dohner H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukaemia by in situ hybridization. Blood 83:1922, 1994
24. Seong DC, Song MY, Henske EP, Zimmerman SO, Champlin RE, Deisseroth AB, Siciliano MJ: Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid. Blood 83:2268, 1994
25. Nacheva E, Holloway T, Carter N, Grace C, White N, Green AR: Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Cancer Genet Cytogenet 80:87, 1995
26. Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA, Soderlund CA, Maslen GL, Everett LA, Rice KM, Coffey AJ, Gregory SG, Gwilliam R, Dunham A, Davies AF, Hassock S, Todd CM, Lehrach H, Huslebos JM, Weissenbach J, Morrow B, Kucherlapati RS, Wadey R, Scambler PJ, Kim UJ, Simon MI, Peyrard M, Xie YG, Carter NP, Durbin R, Dumanski JP, Bentley D, Dunham I: A high-density YAC contig map of human chromosome 22. Nature 377:367, 1995
27. Povey S, Armour J, Farndon P, Haines JL, Knowles M, Olopade F, Pilz A, White JA, Kwiatkowski DJ: Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. Ann Hum Genet 58:177, 1994
28. Northrup H, Lathrop M, Lu S, Daiger S, Beaudet A, O'Briens W: Multilocus linkage analysis with the human argininosuccinate synthetase gene. Genomics 5:442, 1989
29. Harris R, Carter N, Griffiths B, Goudie D, Hampson R, Yates J, Affara N, Ferguson-Smith M: Physical mapping within the tuberous sclerosis linkage group in region 9q32-q34. Genomics 15:265, 1993
30. Kloke O, Niederle N, Qiu JY, Wandl U, Moritz T, Nagel-Heimke M, I Hawig, Opalka B, Seeber S, Becher R: Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br J Haematol 83:399, 1993
31. Kloke O, Niederle N, Opalka B, Hawig I, Seeber S, Becher R: Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: Long-term follow-up. Eur J Haematol 56:78, 1996
32. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia: Chronic myeloid leukaemia, BCR/ABL transcript, response to alpha-interferon and survival. Leukaemia 9:1648, 1995
33. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M: Prolonged survival in chronic myelogenous leukaemia after cytogenetic response to interferon-alpha therapy. Ann Intern Med 122:254, 1995
34. Allan NC, Richards SM, Shepherd PC: UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response. Lancet 345:1392, 1995
35. Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM: Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukaemia patients after bone marrow transplantation. Blood 82:1929, 1993
36. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
37. Chase A, Grand F, Goldman JM, Gordan M: Parameters affecting the interpretation of BCR/ABL fluorescence in-situ hybridisation. Br J Haematol 93:327a, 1996 (abstr, suppl 2)
38. Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW: Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukaemia. Cancer Genet Cytogenet 83:61, 1995
39. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342, 1987
40. Asimakopoulos FA, Holloway TL, Nacheva EP, Scott MA, Fenaux P, Green AR: Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood 87:1561, 1996
41. Fischer K, Scholl C, Salat J, Frohling S, Schlenk R, Bentz M: Design and validation of DNA prohe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukaemia. Blood 88:3962, 1996
42. Mancini M, Nanni M, Cedrone M, Diverio D, Avvisati G, Riccioni R, De Cuia MR, Fenu S, Alimena G: Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. Br J Haematol 91:878, 1995